SummaryObjectivesThis study aimed to determine the prevalence of extended spectrum of beta lactamases (ESBLs), to compare different phenotypic methods for ESBL confirmation and to evaluate the antibiotic resistance patterns among ESBL-producing urinary Escherichia coli.MethodsUrinary E. coli isolates that were resistant to at least one of the three indicator cephalosporins (cefotaxime, cefpodoxime and ceftazidime) were tested for ESBL production using the double disc synergy test (DDST), the inhibitory potentiated disc diffusion (IPDD) test and the quantitative E-strip method.ResultOf the 163 E. coli strains isolated, 80 (49%) were resistant to at least one of the three cephalosporins, and 38 (47.5%) tested positive for ESBLs by the IPDD te...
Resistance to b-lactam antibiotics by gram-negative bacteria, especially Escherichia coli (E. coli),...
Resistance to b-lactam antibiotics by gramnegative bacteria, especially Escherichia coli (E. coli), ...
Abstract: The emergences of extended spectrum-lactamases (ESBLs) are on the rise in hospital setting...
Summary: Objectives: This study aimed to determine the prevalence of extended spectrum of beta lact...
SummaryObjectivesThis study aimed to determine the prevalence of extended spectrum of beta lactamase...
Extended-spectrum β-lactamases (ESBLs) continue to be a major challenge in clinical setups worldwide...
Background: Escherichia coli is one of the most common causative agent of urinary tract infection. I...
ABSTRACT: Extended spectrum beta – lactamases (ESBLs) are on the rise in hospital settings across th...
Possession of virulence factors such as extended spectrum beta lactamase (ESBL) by pathogens general...
Extended-spectrum β-lactamases producing Escherichia coli (ESBL-EC) lend resistance to most β-lactam...
Received 08 November 2017 Accepted 15 February 2018 The incidence of community-acquired UTIs due to ...
The production of extended-spectrum- β lactamases (ESBLs) is an important mechanism for resistan...
Background: Escherichia coli are the most common cause of urinary tract infections in community as w...
Abstract Background Published data on the existence and magnitude of extended spectrum beta-lactamas...
Introduction: Urinary tract infection (UTI) due to extended spectrum beta-lactamase (ESBL)-producing...
Resistance to b-lactam antibiotics by gram-negative bacteria, especially Escherichia coli (E. coli),...
Resistance to b-lactam antibiotics by gramnegative bacteria, especially Escherichia coli (E. coli), ...
Abstract: The emergences of extended spectrum-lactamases (ESBLs) are on the rise in hospital setting...
Summary: Objectives: This study aimed to determine the prevalence of extended spectrum of beta lact...
SummaryObjectivesThis study aimed to determine the prevalence of extended spectrum of beta lactamase...
Extended-spectrum β-lactamases (ESBLs) continue to be a major challenge in clinical setups worldwide...
Background: Escherichia coli is one of the most common causative agent of urinary tract infection. I...
ABSTRACT: Extended spectrum beta – lactamases (ESBLs) are on the rise in hospital settings across th...
Possession of virulence factors such as extended spectrum beta lactamase (ESBL) by pathogens general...
Extended-spectrum β-lactamases producing Escherichia coli (ESBL-EC) lend resistance to most β-lactam...
Received 08 November 2017 Accepted 15 February 2018 The incidence of community-acquired UTIs due to ...
The production of extended-spectrum- β lactamases (ESBLs) is an important mechanism for resistan...
Background: Escherichia coli are the most common cause of urinary tract infections in community as w...
Abstract Background Published data on the existence and magnitude of extended spectrum beta-lactamas...
Introduction: Urinary tract infection (UTI) due to extended spectrum beta-lactamase (ESBL)-producing...
Resistance to b-lactam antibiotics by gram-negative bacteria, especially Escherichia coli (E. coli),...
Resistance to b-lactam antibiotics by gramnegative bacteria, especially Escherichia coli (E. coli), ...
Abstract: The emergences of extended spectrum-lactamases (ESBLs) are on the rise in hospital setting...